4//SEC Filing
Rottinghaus Scott T. 4
Accession 0001062993-25-002561
CIK 0001177648other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:42 PM ET
Size
6.5 KB
Accession
0001062993-25-002561
Insider Transaction Report
Form 4
Rottinghaus Scott T.
Chief Medical Officer
Transactions
- Award
Common Stock
2025-02-12+9,750→ 27,668 total - Tax Payment
Common Stock
2025-02-12$5.59/sh−2,861$15,993→ 24,807 total
Footnotes (2)
- [F1]Represents shares of Enanta common stock issued under performance share units ("PSUs") that vested as a result of performance against two-year research and development milestones in the calendar 2023-2024 period as determined by the Compensation Committee of Enanta's Board of Directors, and then settled with the issuance of the shares of Enanta common stock on February 12, 2025.
- [F2]Represents the number of shares of common stock automatically forfeited by the reporting person pursuant to the terms of the awards to cover withholding taxes due as a result of the settlement of the PSU awards.
Issuer
ENANTA PHARMACEUTICALS INC
CIK 0001177648
Entity typeother
Related Parties
1- filerCIK 0001942407
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:42 PM ET
- Size
- 6.5 KB